The combination of BH3-mimetic ABT-737 with the alkylating agent temozolomide induces strong synergistic killing of melanoma cells independent of p53.

by Steven N Reuland, Nathaniel B Goldstein, Katie A Partyka, David A Cooper, Mayumi Fujita, David A Norris, Yiqun G Shellman
Published 2011-01-01

ABT-737 synergizes with Bortezomib to kill melanoma cells

by Steven N. Reuland, Nathaniel B. Goldstein, Katie A. Partyka, Shilo Smith, Yuchun Luo, Mayumi Fujita, Rene Gonzalez, Karl Lewis, David A. Norris, Yiqun G. Shellman
Published 2012-02-01